Drugs / G-Colony-Stimulating Factor
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT04179929 | Nov 2019 → Nov 2026 expected | acute lymphoblastic leukemia | PETHEMA Foundation | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01503749 Comparator | Jan 2012 → Jul 2013 | cirrhosis of liver | Seoul National University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-Colony-Stimulating Factor | “Resistant patients will receive a second induction with fludarabine, Ara-C, G-Colony-Stimulating Factor (G-CSF) and idarubicin (FLAG-IDA).” NCT04179929 ↗ |
| Known as | G-CSF | “Resistant patients will receive a second induction with fludarabine, Ara-C, G-Colony-Stimulating Factor (G-CSF) and idarubicin (FLAG-IDA).” NCT04179929 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT01503749 ↗ |